Pharma Nordic ApS: Financial statements 2024
CVR: 37842338
Source: annual report 2024, Danish Business Authority
01/10/2023 – 30/09/2024
Pharma Nordic ApS (CVR 37842338) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -5,137 and a net result of DKK -5,137 compared with DKK 55,130 the year before. Equity in the 2024 report amounted to DKK -23,687.
- Revenue
- DKK 0
- Gross Profit
- DKK -5,137
- Profit/Loss
- DKK -5,137
- Equity
- DKK -23,687
- Total Assets
- DKK 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 0 | -5 t. | -5 t. | -24 t. | - |
| 2023 | 100 t. | -117 t. | 55 t. | -19 t. | - |
| 2022 | 52 t. | -108 t. | -110 t. | 876 t. | - |
| 2021 | 366 t. | 322 t. | 300 t. | 1 mio. | 0 |
| 2020 | 26 t. | -102 t. | -140 t. | 725 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Pharma Nordic ApS has published its annual report for 2023. Revenue came to DKK 100,475, and the net result was DKK 55,130.
About Pharma Nordic ApS
Pharma Nordic ApS is a Danish company of the type Anpartsselskab based in Skanderborg, founded in 2016. The company is registered under the industry Anden udlejning af boliger. The management consists of Niels Skovmand Juhl. The company is owned by Niels Skovmand Juhl, Christopher Skovmand Møller Juhl and Stephanie Skovmand Møller Juhl. According to the 2021 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -5,137 the year before. Equity in the 2025 report amounted to DKK -23,687.